SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc., and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis